Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy

Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy

Circulating tumor cells (CTCs) are prognostic markers in a variety of solid tumor malignancies. The potential of CTCs to be used as a liquid biopsy to monitor a patient’s condition and predict drug response and resistance is currently under investigation. Using a negative depletion, enrichment meth...

Full description

Bibliographic Details
Main Authors:	Alejandra eGarcia-Villa, Priya eBalsubramanian, Brandon eMiller, Maryam eLustberg, Bhuvaneswari eRamaswamy, Jeffrey eChalmers
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-10-01
Series:	Frontiers in Oncology
Subjects:	chemotherapy Circulating Tumor Cells (CTCs) metastatic breast cancer gamma H2AX Her2neu
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00128/full

Similar Items

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
by: Laura L. Michel, et al.
Published: (2020-10-01)

Frequency of HER-2 over Expression in the Patients with Breast Cancer after Mastectomy
by: S kargar, et al.
Published: (2013-10-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

In vivo Analysis of H2AX Phosphorylation Induced by γ-Radiation
by: Seyed Mostafa Mir, et al.
Published: (2017-03-01)

Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study
by: Vladimir I. Evdokimov, et al.
Published: (2023-12-01)

The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age
by: Adalberto Merighi, et al.
Published: (2021-11-01)

Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India
by: Abhilash V. B., et al.
Published: (2023-04-01)

Research Progress of HER2 Positive Colorectal Cancer
by: QI Yali, et al.
Published: (2023-01-01)

Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01)

Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01)

Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
by: Asma Shabbir, et al.
Published: (2018-01-01)

Study of human epidermal growth factor receptor (HER2/neu) expression in primary colorectal carcinoma in a tertiary care hospital
by: Mousmi Agrawal, et al.
Published: (2021-01-01)

Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
by: O A Shisterova, et al.
Published: (2007-03-01)

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
by: Lee Heejeong, et al.
Published: (2012-08-01)

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
by: Alessandro D. Santin, et al.
Published: (2017-02-01)

Predictive factors of breast cancer evaluated by immunohistochemistry Fatores preditivos do câncer de mama avaliados pela imuno-histoqu��mica
by: Helenice Gobbi, et al.
Published: (2008-04-01)

The kinetics of γ-H2AX during radiotherapy of head and neck cancer potentially allow for prediction of severe mucositis
by: Kazmierska Joanna, et al.
Published: (2020-02-01)

Downstream events initiated by expression of FSHD-associated DUX4: Studies of nucleocytoplasmic transport, γH2AX accumulation, and Bax/Bak-dependence
by: Isabel F. Masteika, et al.
Published: (2022-02-01)

Estudo comparativo entre os métodos LSAB®+ e Herceptest® para a detecção de HER-2/neu em carcinoma de mama A comparative study between LSAB®+ and Herceptest® in the detection of HER-2/neu in breast carcinoma
by: Alexandre de Oliveira Sales, et al.
Published: (2004-08-01)

EGFR and HER2neu Expression in Gall Bladder Carcinoma and Its Association with Clinicopathological Parameters - An Institutional Experience from North India
by: Inara Abeer, et al.
Published: (2021-03-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
by: Anamika Gupta, et al.
Published: (2023-01-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017-02-01)

HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin
by: Anne Mullin, et al.
Published: (2020-12-01)

Breast Biomarkers-Comparison on Whole Section and Tissue Microarray Section
by: Sneha S Chavan, et al.
Published: (2017-03-01)

بررسی ایمونوهیستولوژیک بیانHER2 و P53 در مننژیوم و ارتباط آنها با درجه هیستولوژیک
by: سید عباس طباطبایی یزدی, et al.
Published: (2017-09-01)

Senescence-Associated Heterochromatin Foci Suppress γ-H2AX Focus Formation Induced by Radiation Exposure
by: Takashi Oizumi, et al.
Published: (2024-03-01)

Nerve Injury-Induced γH2AX Reduction in Primary Sensory Neurons Is Involved in Neuropathic Pain Processing
by: Yan Zhang, et al.
Published: (2023-06-01)

Association of Caspase 3 Activation and H2AX γ Phosphorylation in the Aging Brain: Studies on Untreated and Irradiated Mice
by: Nadia Gionchiglia, et al.
Published: (2021-09-01)

A Survey on the Possibility of Utilizing gamma H2AX as a Biodosimeter in Radiation Workers
by: Mostafa Mir, et al.
Published: (2015-05-01)

A Survey on the Possibility of Utilizing gamma H2AX as a Biodosimeter in Radiation Workers
by: Mostafa Mir, et al.
Published: (2015-05-01)

HER-2/NEU Ekspresyonun Saptanmasinda İmmunohistokimyasal ve Fish Yöntemi Arasında Diskordansin Belirlenmesi Önemli midir?
by: Berna Bozkurt DUMAN, et al.
Published: (2014-07-01)

Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
by: M. Ruhul Quddus, et al.
Published: (2020-05-01)

TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
by: Yeşim Eralp
Published: (2009-01-01)

Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma
by: Se Been Kim, et al.
Published: (2023-09-01)